160 related articles for article (PubMed ID: 1381268)
21. Prediction of the development of hepato-cellular-carcinoma in patients with liver cirrhosis by the serial determinations of serum alpha-L-fucosidase activity.
Ishizuka H; Nakayama T; Matsuoka S; Gotoh I; Ogawa M; Suzuki K; Tanaka N; Tsubaki K; Ohkubo H; Arakawa Y; Okano T
Intern Med; 1999 Dec; 38(12):927-31. PubMed ID: 10628928
[TBL] [Abstract][Full Text] [Related]
22. Serum alpha L-fucosidase enzyme activity in ovarian and other female genital tract tumors.
Abdel-Aleem H; Ahmed A; Sabra AM; Zakhari M; Soliman M; Hamed H
Int J Gynaecol Obstet; 1996 Dec; 55(3):273-9. PubMed ID: 9003953
[TBL] [Abstract][Full Text] [Related]
23. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Fabris C; Basso DA; Leandro G; Meggiato T; Elba S; Panozzo MP; Del Favero G; Fogar P; Di Mario F; Naccarato R
Cancer; 1991 Oct; 68(8):1795-8. PubMed ID: 1717126
[TBL] [Abstract][Full Text] [Related]
24. [Comparative study of 3 serum markers of primary liver cancer: ferritin, alpha-fetoprotein and alpha-fucosidase].
Bourel M; Deugnier Y; Brissot P; Leray G; Le Gall JY
Bull Acad Natl Med; 1987 Mar; 171(3):359-64. PubMed ID: 2444315
[No Abstract] [Full Text] [Related]
25. [Value of serum glycosidase spectrum in the diagnosis of hepatocellular carcinoma].
Zhang SM
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):143-6. PubMed ID: 1319891
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of hepatocellular carcinoma.
Gomaa AI; Khan SA; Leen EL; Waked I; Taylor-Robinson SD
World J Gastroenterol; 2009 Mar; 15(11):1301-14. PubMed ID: 19294759
[TBL] [Abstract][Full Text] [Related]
27. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
[TBL] [Abstract][Full Text] [Related]
28. Clinical relevance of serum endoglin level in Egyptian hepatocellular carcinoma patients.
Elnemr DM; Abdel-Azeez HA; Labib HA; Abo-Taleb FM
Clin Lab; 2012; 58(9-10):1023-8. PubMed ID: 23163119
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma.
Jia X; Gao Y; Zhai D; Liu J; Cai J; Wang Y; Jing L; Du Z
Technol Cancer Res Treat; 2016 Dec; 15(6):780-786. PubMed ID: 26370140
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis].
Lee HY; Jung JH; Kang YS; Kim YS; Moon HS; Park KO; Lee YS; Kim SM; Seo SW; Lee SW; Kim SH; Lee BS; Kim NJ
Korean J Gastroenterol; 2004 Apr; 43(4):252-9. PubMed ID: 15100489
[TBL] [Abstract][Full Text] [Related]
31. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
[TBL] [Abstract][Full Text] [Related]
32. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis.
Sarwar S; Khan AA; Tarique S
J Coll Physicians Surg Pak; 2014 Jan; 24(1):18-22. PubMed ID: 24411536
[TBL] [Abstract][Full Text] [Related]
33. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK
Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
35. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
[TBL] [Abstract][Full Text] [Related]
36. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of transforming growth factor alpha and vascular endothelial growth factor in diagnosis of hepatocellular carcinoma.
El-Sherif WT; Makhlouf NA; El-Gendi SS; Hassan HI; Herdan OM
Egypt J Immunol; 2012; 19(2):53-65. PubMed ID: 23885407
[TBL] [Abstract][Full Text] [Related]
38. Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.
Li J; Cheng ZJ; Liu Y; Yan ZL; Wang K; Wu D; Wan XY; Xia Y; Lau WY; Wu MC; Shen F
Oncotarget; 2015 Apr; 6(11):9551-63. PubMed ID: 25871387
[TBL] [Abstract][Full Text] [Related]
39. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?
Morace C; Cucunato M; Bellerone R; De Caro G; Crinò S; Fortiguerra A; Spadaro F; Zirilli A; Alibrandi A; Consolo P; Luigiano C; Resta ML; Ferraù O; Spadaro A
Eur J Intern Med; 2012 Sep; 23(6):e157-61. PubMed ID: 22863442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
